Salomons Institute for Applied Psychology, Canterbury Christ Church University, 1 Meadow Road
Royal Tunbridge Wells, Tunbridge Wells, TN1 2YG, United Kingdom
NCT Number: NCT05749029
The goal of this research study is to evaluate a programme that is based on Compassionate Mind Training (CMT) over four-weeks. The programme intends to share information and strategies to reduce diabetes distress, self-criticism, and shame, and improve physical health in people who have Type 1 and Type 2 Diabetes Mellitus.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Royal Tunbridge Wells, Tunbridge Wells, TN1 2YG, United Kingdom
This Randomised Controlled Trial (RCT) will compare a CMT intervention for people with Type 1 and Type 2 Diabetes Mellitus with a waitlist control group who will be given access after the study.
The outcome measures will be completed at baseline (week 0), post-intervention (week 4), and at follow-up (week 8).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This is a four-week self-compassion course supplied by Balanced Minds. The owner of Balanced Minds is a Consultant to this study, who will be providing access to participants.
The self-help, self-compassion course is based on Compassionate Mind Training. This provides participants with opportunities to develop skills and attributes of compassion through a weekly 30-minute video on a specified topic, a 10-minute compassionate exercise that participants are encouraged to engage in daily for the week and a brief summary of the compassionate topic. The topics of the course are:
Other names: Online Self-Compassion Course
Time frame: Post-intervention (week 4)
The DDS is a 17-item measure of problems and hassles related to diabetes.
The DDS establishes a total mean score and a mean score for its four sub-scales. Scores will range from 1 to 6. Mean scores of 3 or above is considered distress worthy of clinical attention.
Time frame: Post-intervention (week 4)
The EISS is an eight-item scale measuring external and internal dimensions of shame.
Higher scores indicate higher levels of shame and a total score varies between 8 and 40.
Time frame: Post-intervention (week 4)
The FSCRS is a 22-item scale with statements measuring inadequate self, hated self and reassured self.
Scores will range from 0 to 88.
Time frame: Post-intervention (week 4)
The FCS is a 15-item measure of fear of compassion towards self.
Scores will range from 0 to 60. Higher scores indicate greater fear of compassion.
Time frame: Post-intervention (week 4)
14-item measure assessing mental wellbeing in the non-clinical sample. Scores on the WEMWBS will range from 14 to 70. Higher scores indicate greater positive mental wellbeing.
Time frame: Post-intervention (week 4)
The CEAS is a 13-item measure of compassionate engagement and action.
The engagement sub-scale will establish a score between 6 and 60.
The action sub-scale will establish a score between 4 and 40.
Time frame: Follow-up (week 8)
Participants will be asked to self-report a blood glucose (HbA1c) level taken by a healthcare provider in the past three to six months at baseline and at one-month post-intervention.
Higher HbA1c levels indicate poorer diabetes control.
Time frame: Follow-up (week 8)
Please see description above.
Time frame: Follow-up (week 8)
Please see description above.
Time frame: Follow-up (week 8)
Please see description above.
Time frame: Follow-up (week 8)
Please see description above.
Time frame: Follow-up (week 8)
Please see description above.
Time frame: Follow-up (week 8)
Please see description above.
Canterbury Christ Church University
Other
An Online, Compassion Intervention to Improve Shame, Self-criticism, and Physical Wellbeing in Adults with Type 1 and Type 2 Diabetes Mellitus (T1DM; T2DM)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05229718
Autoimmune Diseases, Diabetes Mellitus
Boston, Massachusetts, United States
View Trial DetailsNCT07403565
Autoimmune Diseases, Diabetes Mellitus
Beijing, Beijing Municipality, China
View Trial DetailsNCT06418880
Autoimmune Diseases, Diabetes Mellitus
Stanford, California, United States
View Trial DetailsNCT05893797
Autoimmune Diseases, Diabetes Mellitus
Strasbourg, Alsace, France
View Trial Details